EBS - Emergent BioSolutions Inc. Stock Analysis | Stock Taper
Logo

About Emergent BioSolutions Inc.

https://www.emergentbiosolutions.com

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States.

Joseph C. Papa Jr.,

CEO

Joseph C. Papa Jr.,

Compensation Summary
(Year 2024)

Salary $800,000
Bonus $1,000,000
Stock Awards $516,000
Option Awards $1,973,050
Incentive Plan Pay $1,566,474
All Other Compensation $7,038
Total Compensation $5,862,562
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Went public November 15, 2006
Method of going public IPO
Full time employees 900

ETFs Holding This Stock

Ratings Snapshot

Rating : B

Discounted Cash Flow 1
Return On Equity 4
Return On Assets 4
Debt To Equity 1
Price To Earnings 3
Price To Book 4
Overall Score 3

Most Recent Analyst Grades

Grade Summary

Buy 1

Showing Top 1 of 1

Price Target

Target High $65
Target Low $38
Target Median $51.5
Target Consensus $51.5

Institutional Ownership

Summary

% Of Shares Owned 69.83%
Total Number Of Holders 262

Showing Top 3 of 262